Left ventricular function and C-reactive protein levels in acute myocardial infarction
- PMID: 20346306
- PMCID: PMC2847591
- DOI: 10.1016/j.amjcard.2009.11.025
Left ventricular function and C-reactive protein levels in acute myocardial infarction
Abstract
To examine left ventricular (LV) function in patients after acute myocardial infarction (AMI) and assess its relation to C-reactive protein (CRP) as a measure of the early inflammatory response. We measured the CRP levels early after AMI and correlated them with the early structural and functional cardiac alterations. From November 2002 to December 2007, we prospectively enrolled community subjects who had experienced an AMI, as defined by standardized criteria, measured the CRP level, and obtained an echocardiogram. The study consisted of 514 patients (mean age 67 +/- 15 years, 59% men). CRP was measured early after symptom onset (median 6.1 hours; twenty-fifth to seventy-fifth percentile 2.2 to 11.1). The median CRP level was 4.8 mg/L (twenty-fifth to seventy-fifth percentile 1.8 to 24). The echocardiograms were obtained at a median of 1 day after AMI. The wall motion score index, LV ejection fraction, and LV diameter were similar across the CRP tertiles (all p >0.05). Greater CRP levels were associated with the presence of moderate or severe diastolic dysfunction (p = 0.002) and moderate or severe mitral regurgitation (p <0.001). The association with moderate or severe mitral regurgitation was independent of the clinical characteristics and ST-segment elevation status. In conclusion, at the initial phase of AMI, CRP elevation was associated with the presence and severity of mitral regurgitation and diastolic dysfunction. This suggests that inflammation is related to the ventricular remodeling processes, independently of LV systolic function.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Association between C-reactive protein level and echocardiography assessed left ventricular function in first ST-segment elevation myocardial infarction patients who underwent primary coronary intervention.J Cardiol. 2014 Jun;63(6):402-8. doi: 10.1016/j.jjcc.2013.10.013. Epub 2013 Dec 2. J Cardiol. 2014. PMID: 24299986
-
Impact of serum C-reactive protein elevation on the left ventricular spherical change and the development of mitral regurgitation after anterior acute myocardial infarction.Cardiology. 2007;107(4):386-94. doi: 10.1159/000099057. Epub 2007 Feb 6. Cardiology. 2007. PMID: 17284900
-
Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure.Am J Cardiol. 2008 Feb 1;101(3):370-3. doi: 10.1016/j.amjcard.2007.08.038. Am J Cardiol. 2008. PMID: 18237602
-
C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up.Clin Cardiol. 2018 Sep;41(9):1201-1206. doi: 10.1002/clc.23017. Epub 2018 Sep 20. Clin Cardiol. 2018. PMID: 29952015 Free PMC article. Clinical Trial.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
Cited by
-
Serum Biomarkers for Chemotherapy Cardiotoxicity Risk Detection of Breast Cancer Patients.Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3355-3363. doi: 10.31557/APJCP.2021.22.10.3355. Asian Pac J Cancer Prev. 2021. PMID: 34711013 Free PMC article.
-
Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer.Front Oncol. 2020 Apr 24;10:628. doi: 10.3389/fonc.2020.00628. eCollection 2020. Front Oncol. 2020. PMID: 32391281 Free PMC article. Review.
-
Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients.Front Oncol. 2014 Oct 9;4:277. doi: 10.3389/fonc.2014.00277. eCollection 2014. Front Oncol. 2014. PMID: 25346912 Free PMC article. Review.
-
Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.Inflamm Res. 2012 Jul;61(7):725-34. doi: 10.1007/s00011-012-0466-2. Epub 2012 Mar 24. Inflamm Res. 2012. PMID: 22446726 Free PMC article.
-
Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure.Int J Mol Sci. 2020 Jan 26;21(3):807. doi: 10.3390/ijms21030807. Int J Mol Sci. 2020. PMID: 31991903 Free PMC article. Clinical Trial.
References
-
- Hellermann JP, Goraya TY, Jacobsen SJ, Weston SA, Reeder GS, Gersh BJ, Redfield MM, Rodeheffer RJ, Yawn BP, Roger VL. Incidence of heart failure after myocardial infarction: is it changing over time? American Journal of Epidemiology. 2003;157:1101–1107. - PubMed
-
- Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543–1553. - PubMed
-
- Nunez J, Nunez E, Bodi V, Sanchis J, Minana G, Mainar L, Santas E, Merlos P, Rumiz E, Darmofal H, Heatta AM, Llacer A. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101:747–752. - PubMed
-
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454. - PubMed
-
- Gabriel AS, Martinsson A, Wretlind B, Ahnve S. IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Intern Med. 2004;15:523–528. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous